Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 16, 2025 12:18 ET | Source: Equity Insider

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic...
December 16, 2025 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Announces Compelling Clinical Activity of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients with Androgen Receptor Mutations

In mCRPC patients with androgen receptor (AR) mutations, treatment with MRT-2359 in combination with enzalutamide led to a 100% PSA response rate (4 of 4 patients) and a 100% disease control rate,...
December 15, 2025 11:30 ET | Source: Ipsen Pharma

Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline

PARIS, FRANCE, 15 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced it has completed the acquisition of ImCheck Therapeutics, a private French biotechnology company pioneering...
December 15, 2025 10:54 ET | Source: USA News Group

THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis

VANCOUVER, British Columbia, Dec. 15, 2025 (GLOBE NEWSWIRE) -- USANewsGroup.com Market Intelligence Brief – The market is repricing risk around a single variable: detection. The most dangerous...
December 15, 2025 10:00 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer

AGOURA HILLS, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) in collaboration with the Brush and Key Foundation, today announced the publication of a...
December 12, 2025 08:15 ET | Source: SNS Insider pvt ltd

Global Large Molecule Drug Discovery Outsourcing Market to Hit USD 5.59 Billion by 2032 Driven by Increasing Demand for Biologics – SNS Insider

Austin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- As per SNS Insider Research, The Large Molecule Drug Discovery Outsourcing Market size was valued at USD 2.84 billion in 2024 and is expected to reach USD...
December 11, 2025 13:00 ET | Source: MAIA Biotechnology, Inc.

MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates

CHICAGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Ateganosine (THIO, 6-thio-2'-deoxyguanosine), a first-in-class telomere-targeting therapy under development by MAIA Biotechnology (NYSE American: MAIA),...
December 11, 2025 08:00 ET | Source: Bionano Genomics

Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025

SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA....
December 11, 2025 07:30 ET | Source: Autobahn Labs

Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines

Autobahn Labs and Astellas form a strategic partnership to source and develop early-stage drug discovery programs from academia.
December 11, 2025 07:00 ET | Source: Molecular Partners

Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics

Chaired by globally renowned nuclear medicine expert Prof. Ken Herrmann, M.D. Other Board members James Cook, Jason Lewis, Ph.D., and Michael Morris, M.D. bring significant clinical and industry...